NASDAQ:OSUR - OraSure Technologies Stock Price, Forecast & News

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

OraSure Technologies, Inc. (NASDAQ:OSUR) released its earnings results on Wednesday, February, 19th. The medical instruments supplier reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.03. The medical instruments supplier had revenue of $49.67 million for the quarter, compared to the consensus estimate of $47.03 million. OraSure Technologies had a return on equity of 2.72% and a net margin of 10.77%. The firm's revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.16 earnings per share. View OraSure Technologies' Earnings History.

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for OraSure Technologies.

OraSure Technologies issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, February, 19th. The company provided EPS guidance of -0.1--0.07 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.24. The company issued revenue guidance of $145-155 million, compared to the consensus revenue estimate of $170.8 million.

1 Wall Street analysts have issued 12-month price objectives for OraSure Technologies' stock. Their forecasts range from $8.00 to $8.00. On average, they expect OraSure Technologies' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 33.3% from the stock's current price. View Analyst Price Targets for OraSure Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for OraSure Technologies.

News articles about OSUR stock have trended very negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. OraSure Technologies earned a coverage optimism score of -3.5 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for OraSure Technologies.

OraSure Technologies saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 4,000,000 shares, an increase of 12.4% from the January 30th total of 3,560,000 shares. Based on an average daily volume of 502,600 shares, the days-to-cover ratio is currently 8.0 days. Approximately 6.6% of the shares of the company are short sold. View OraSure Technologies' Current Options Chain.

Some companies that are related to OraSure Technologies include Align Technology (ALGN), Cooper Companies (COO), West Pharmaceutical Services (WST), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), XOMA (XOMA), Energy Transfer LP Unit (ET), Overstock.com (OSTK), Ford Motor (F), Celldex Therapeutics (CLDX), CBL & Associates Properties (CBL), Opko Health (OPK) and SandRidge Permian Trust (PER).

OraSure Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (6.79%), American Capital Management Inc. (5.12%), State Street Corp (4.17%), Bank of America Corp DE (1.79%), Bank of New York Mellon Corp (1.46%) and Geode Capital Management LLC (1.41%). Company insiders that own OraSure Technologies stock include Charles W Patrick, Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.

OSUR stock was sold by a variety of institutional investors in the last quarter, including Penn Capital Management Co. Inc., Renaissance Technologies LLC, Assenagon Asset Management S.A., Oxford Asset Management LLP, Marshall Wace LLP, Goldman Sachs Group Inc., Public Sector Pension Investment Board and Arizona State Retirement System. View Insider Buying and Selling for OraSure Technologies.

OSUR stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE, UBS Group AG, Echo Street Capital Management LLC, Jacobs Levy Equity Management Inc., Acadian Asset Management LLC, ETRADE Capital Management LLC, Envestnet Asset Management Inc. and Earnest Partners LLC. Company insiders that have bought OraSure Technologies stock in the last two years include Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OSUR stock can currently be purchased for approximately $6.00.

OraSure Technologies has a market capitalization of $370.38 million and generates $154.60 million in revenue each year. The medical instruments supplier earns $16.66 million in net income (profit) each year or $0.13 on an earnings per share basis. OraSure Technologies employs 398 workers across the globe.View Additional Information About OraSure Technologies.

The official website for OraSure Technologies is http://www.orasure.com/.

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]